Sequencing. 1.5.1. Sequence TAB work in conjunction with work by the Contractor. TAB work and milestones shall be incorporated in the General Contractor’s Construction Schedule.
1.5.2. Sequence TAB work to commence after completion of systems. TAB work shall be completed as a prerequisite for Substantial Completion of the Project.
Sequencing. As stated in Section 5, it is expressly understood, agreed and expected that the Closing will be completed before Buyer has had an opportunity to wire the Purchase Price to Seller, but that nonetheless upon the applicable Closing all title and ownership to and in the applicable Livestock shall transfer to Buyer.
Sequencing. It is expressly understood, agreed and expected that the applicable Closing might be completed before Seller has had an opportunity to present the Satisfaction Documents to the Issuing Bank and thereby receive the Purchase Price from the Issuing Bank, but that nonetheless upon the applicable Closing (i.e., upon satisfaction or express waiver in writing of all the closing conditions as set forth herein) all title and ownership to and in the applicable Shipment Gold (i.e., including the refined gold resulting from refining the 50-100 kilogram sample of Gold selected by Buyer, or the dip samples (as the case may be), and also including the remaining Gold in doré bar or other form and all other minerals contained in the doré) shall automatically transfer to Buyer – and without any requirement for further instrument of transfer on the part of Seller.
Sequencing. Roche may, in its discretion, perform sequencing on a potential or selected Cell Context of any [***] Phenomap or Neuroscience Phenomap that is the subject of Stage 0-1 Activities in order to (a) for [***] Phenomap or Neuroscience Phenomaps, aid the evaluation and selection of the Cell Context for such Phenomap (or a potential future Neuroscience Phenomap); or (b) to supplement the Parties’ identification of Collaboration Insights for further validation in the Neuro Field, including the Parties’ activities under the Multi-Modal Research Plans, or in the [***] Field. Recursion will provide protocols it created or used in Stage 0-1 Activities for its arrayed perturbation assay for the [***] Phenomaps and Neuroscience Phenomaps, including [***], at Recursion’s expense, to enable Roche’s sequencing activities in accordance with the applicable Research Plan; [***]; and provided further that, [***]. Roche may provide, at its discretion and subject to agreed-upon information security measures, any or all of such Sequencing Data to Recursion, solely for use by Recursion as set forth in Section 8.5. In addition, [***].
Sequencing. For the avoidance of doubt, all parties to this Amendment agree that (a) the assignments described in this Section 6 shall be deemed to have been consummated prior to the actions described in Section 7 of this Amendment and (b) the effectiveness of all provisions in this Amendment (other than this Section 6) shall be deemed to have occurred immediately following the consummation of the assignments described in this Section 6. 7.
Sequencing. The vast majority of samples with an adequate amount of good quality DNA perform well in the FMI assay. If underperformance is noted, the Sponsor Contact will be notified to discuss steps forward. Refer to the SOW appendices for the list of genes in each assay.
Sequencing. The parties hereto covenant and agree that the following actions, amendments and/or consents are occurring substantially simultaneously immediately following the execution and delivery of this Agreement, but are nonetheless agreed to be occurring in the following order regardless of the timing of the execution and delivery of the documents and instruments related thereto:
(a) The waiver by each of the Sellers of interest accrued but u npaid with respect to the Senior Notes (Other) (as defined in the Senior Indenture referred to below) held by such Seller, which waiver each such Seller hereby grants.
(b) The termination of the Registration Rights Agreement dated as of December 12, 1996 (the "Existing Registration Rights Agreement") among the Company, BT, Mass Mutual, Oppenheimer, Mellon, Lindxxx xxx the Junior Lenders, to which termination the Company, BT, Mass Mutual, Oppenheimer, Mellon, Lindxxx xxx the Junior Lenders, as the holders of all the Registrable Securities thereunder, hereby agree effective immediately following the waiver granted under paragraph (a) above.
(c) The execution and delivery of the Securities Purchase Agreement.
(d) The acquisition of the Securities (as such term is defined in the Securities Purchase Agreement) by the Exchange Buyers from the Sellers pursuant to the Securities Purchase Agreement, including the payment of the purchase price for such Securities by the Exchange Buyers to the Sellers.
(e) The consents, agreements and amendments set forth on Exhibit A hereto to the Amended and Restated Collateralized Note Indenture dated as of December 12, 1996 (the "Senior Indenture") between the Company and the Senior Trustee, to which consents, agreements and amendments the Company and BT, Mellon, Oppenheimer, the Exchange Buyers and Lindxxx, xx all of the Holders under the Senior Indenture immediately following the acquisition referred to in paragraph (d) above, hereby agree effective immediately following such acquisition; and the consents and amendments set forth on Exhibit B hereto to the Amended and Restated Junior Subordinated Debenture Indenture dated as of December 12, 1996 (the "Junior Indenture") between the Company and IBJ Schrxxxx Xxxk & Trust Company, as trustee (the "Junior Trustee"), to which consents and amendments the Company and the Junior Lenders, as all of the Holders under the Junior Indenture hereby agree.
(f) The amendments set forth on Exhibit C hereto to the Letter of Credit and Reimbursement Agreement dated ...
Sequencing. Investments will be financed by the public sector. Their sequencing has been designed to enable: (i) AC-IWRM to be exposed to international best practices for IWRM and to adapt these to local conditions prior to implementation; (ii) the selection of a medium irrigation subproject to rapidly demonstrate principals of IWRM and show quick results in improved water resources management and efficiency, WUCS strengthening and improved agricultural practices; (iii) progressive capacity development of AC-IWRM, KNNL, CADA and WUCS; and (iv) testing and innovation, with a feedback mechanism to incorporate lessons learned into future tranches.
Sequencing. For samples with band shifts on SSCP or RFLP, genomic DNA PCR amplified products were sequenced using fluorescent labelled primers and analysed by ABI377 sequencer (Xxxxxx Xxxxx), and associated Genescan software. In addition, samples (except the 2 difficult controls described above) were subcloned into JM109 E. coli cells with the pGEM-T vector (Promega) according to the manufacturer’s instructions. Subclones were then sequenced in the same way as genomic samples. Genomic electropherograms were analysed by subtracting the known sequence from the two superimposed sequences, leaving the mutant sequence. This was then confirmed on the subcloned sequence.
Sequencing. Key milestones will be: • Approval of the Twinning project fiche; • Circulation of the Twinning Project Fiche to Member State National Contact Points; • Completion of the selection of the twinning partner; • Signature of the Twinning contract; • Commencement of the implementation of the twinning (inter alia, the arrival in the country of the Resident Twinning Adviser); • Preparation of Project Work Plan • End of the implementation period; • Submission of the final report; • Twinning review mission (6 to 12 months after end of the project).
